Levorphanol tartrate (powder)

• CAT Number: I030736
• CAS Number: 5985-38-6
• Molecular Formula: C21H33NO9
• Molecular Weight: 443.49
• Purity: 98%
• Synonyms: Levorphanol tartrate; Levo-dromoran; Levorphanol D-tartrate dihydrate
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: (4bR,8aR,9R)-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthren-3-ol (2S,3S)-2,3-dihydroxysuccinate dihydrate
• InChI: InChI=1S/C17H23NO.C4H6O6.2H2O/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17;5-1(3(7)8)2(6)4(9)10;;/h5-6,11,14,16,19H,2-4,7-10H2,1H3;1-2,5-6H,(H,7,8)(H,9,10);2*1H2/t14-,16+,17+;1-,2-;;/m00../s1
• InChIKey: UMZNDVASJKIQCB-ULFFVNIPSA-N
• SMILES: [H][C@@]12CCCC[C@]13C4=CC(O)=CC=C4C[C@H]2N(C)CC3.O=C(O)[C@@H](O)[C@H](O)C(O)=O.[H]O[H].[H]O[H]

Levorphanol tartrate is a synthetic morphine analog that is a narcotic analgesic and μ opioid receptor agonist.
Levorphanol tartrate (powder) is discontinued (DEA controlled substance).

Reference

1: Comparison table: some oral/topical opioid analgesics. Med Lett Drugs Ther. 2018 Apr 9;60(1544):e64-e67. PubMed PMID: 29664447.
2: Opioids for pain. Med Lett Drugs Ther. 2018 Apr 9;60(1544):57-64. PubMed PMID: 29664446.
3: Le Rouzic V, Narayan A, Hunkle A, Marrone GF, Lu Z, Majumdar S, Xu J, Pan YX, Pasternak GW. Pharmacological Characterization of Levorphanol, a G-Protein Biased Opioid Analgesic. Anesth Analg. 2018 Apr 11. doi: 10.1213/ANE.0000000000003360. [Epub ahead of print] PubMed PMID: 29649035.
4: Watson AR, Roberts A. Identifying Levorphanol Ingestion Using Urine Biomarkers in Health Care Patients. Pain Physician. 2018 Mar;21(2):E167-E171. PubMed PMID: 29565959.
5: Reddy A, Ng A, Mallipeddi T, Bruera E. Levorphanol for Treatment of Intractable Neuropathic Pain in Cancer Patients. J Palliat Med. 2018 Mar;21(3):399-402. doi: 10.1089/jpm.2017.0475. Epub 2018 Jan 29. PubMed PMID: 29377758.
6: Els C, Jackson TD, Kunyk D, Lappi VG, Sonnenberg B, Hagtvedt R, Sharma S, Kolahdooz F, Straube S. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017 Oct 30;10:CD012509. doi: 10.1002/14651858.CD012509.pub2. Review. PubMed PMID: 29084357.
7: Tran HQ, Chung YH, Shin EJ, Tran TV, Jeong JH, Jang CG, Nah SY, Yamada K, Nabeshima T, Kim HC. MK-801, but not naloxone, attenuates high-dose dextromethorphan-induced convulsive behavior: Possible involvement of the GluN2B receptor. Toxicol Appl Pharmacol. 2017 Nov 1;334:158-166. doi: 10.1016/j.taap.2017.09.010. Epub 2017 Sep 13. PubMed PMID: 28916251.
8: Masocha W, González LG, Agil A. Distinguishing subgroups among μ-opioid receptor agonists using Na(+),K(+)-ATPase as an effector mechanism. Eur J Pharmacol. 2016 Mar 5;774:43-9. doi: 10.1016/j.ejphar.2016.01.010. Epub 2016 Jan 26. PubMed PMID: 26825542.
9: Gudin J, Fudin J, Nalamachu S. Levorphanol use: past, present and future. Postgrad Med. 2016 Jan;128(1):46-53. doi: 10.1080/00325481.2016.1128308. Epub 2015 Dec 27. Review. PubMed PMID: 26635068.
10: Pham TC, Fudin J, Raffa RB. Is levorphanol a better option than methadone? Pain Med. 2015 Sep;16(9):1673-9. doi: 10.1111/pme.12795. Epub 2015 Aug 26. Review. PubMed PMID: 26307179.
11: DePriest AZ, Puet BL, Holt AC, Roberts A, Cone EJ. Metabolism and Disposition of Prescription Opioids: A Review. Forensic Sci Rev. 2015 Jul;27(2):115-45. Review. PubMed PMID: 26227254.
12: Bertaso A, Musile G, Gottardo R, Seri C, Tagliaro F. Chiral analysis of methorphan in opiate-overdose related deaths by using capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Sep 1;1000:130-5. doi: 10.1016/j.jchromb.2015.07.024. Epub 2015 Jul 19. PubMed PMID: 26226106.
13: Brown R, Howard R, Candy B, Sampson EL. Opioids for agitation in dementia. Cochrane Database Syst Rev. 2015 May 14;(5):CD009705. doi: 10.1002/14651858.CD009705.pub2. Review. PubMed PMID: 25972091.
14: Prommer E. Levorphanol: revisiting an underutilized analgesic. Palliat Care. 2014 May 11;8:7-10. doi: 10.4137/PCRT.S13489. eCollection 2014. Review. PubMed PMID: 25278763; PubMed Central PMCID: PMC4168847.
15: Kurogi K, Chepak A, Hanrahan MT, Liu MY, Sakakibara Y, Suiko M, Liu MC. Sulfation of opioid drugs by human cytosolic sulfotransferases: metabolic labeling study and enzymatic analysis. Eur J Pharm Sci. 2014 Oct 1;62:40-8. doi: 10.1016/j.ejps.2014.05.003. Epub 2014 May 14. PubMed PMID: 24832963; PubMed Central PMCID: PMC4459640.
16: Wu HY, Cunningham BT. Point-of-care detection and real-time monitoring of intravenously delivered drugs via tubing with an integrated SERS sensor. Nanoscale. 2014 May 21;6(10):5162-71. doi: 10.1039/c4nr00027g. PubMed PMID: 24699532.
17: Atkinson TJ, Fudin J, Pandula A, Mirza M. Medication pain management in the elderly: unique and underutilized analgesic treatment options. Clin Ther. 2013 Nov;35(11):1669-89. doi: 10.1016/j.clinthera.2013.09.008. Epub 2013 Oct 22. Review. PubMed PMID: 24161287.
18: Faskowitz AJ, Kramskiy VN, Pasternak GW. Methadone-induced hypoglycemia. Cell Mol Neurobiol. 2013 May;33(4):537-42. doi: 10.1007/s10571-013-9919-6. Epub 2013 Mar 7. PubMed PMID: 23467779; PubMed Central PMCID: PMC3622167.
19: Schattauer SS, Miyatake M, Shankar H, Zietz C, Levin JR, Liu-Chen LY, Gurevich VV, Rieder MJ, Chavkin C. Ligand directed signaling differences between rodent and human κ-opioid receptors. J Biol Chem. 2012 Dec 7;287(50):41595-607. doi: 10.1074/jbc.M112.381368. Epub 2012 Oct 19. PubMed PMID: 23086943; PubMed Central PMCID: PMC3516711.
20: Gyulai Z, Udvardy A, Cs Bényei A, Fichna J, Gach K, Storr M, Tóth G, Antus S, Berényi S, Janecka A, Sipos A. Synthesis and opioid activity of novel 6-ketolevorphanol derivatives. Med Chem. 2013 Feb;9(1):1-10. PubMed PMID: 22741803.